Medicament for treating aplastic anemia

Abstract

The invention discloses a medicament for treating regenerative anemia which is prepared from Chinese herbs of ginseng, cow-bezoar, pulp of dogwood fruit, polygala root, banksia rose, prepared rhizome of rehmannia, white atractylodes rhizome, licorice root, astragalus root, poria cocos, Chinese caterpillar fungus, cimicifuga rhizome, spine date seed, hairy deerhorn, longan pulp, Chinese angelica root, poria with hostwood, Cinnamomum cassia, slice of aconite, schisandra fruit, dried ginger, root of red rooted saliva and motherwort.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines and relates to a medicine for treating aplastic anemia. Background technique [0002] Aplastic anemia has a high incidence rate in recent years. Aplastic anemia is referred to as aplastic anemia. It is due to a variety of reasons that cause a significant decrease in bone marrow hematopoietic tissue and bone marrow hematopoietic failure. Typical symptoms are: progressive anemia, bleeding, infection and whole blood cells In traditional Chinese medicine, it belongs to the category of "consumption of deficiency and blood disease". The disease is generally caused by factors such as chemistry, treatment, and infection. Symptoms, and fever is easy to repeat, skin has bleeding points, pale tongue, thin white fur, deep thready or thready pulse, and some patients have gum infection, anorectal inflammation, dry and itchy throat, etc. The main feature of the blood picture during aplasti...

AI Technical Summary

Problems solved by technology

Western medicine treatment of aplastic anemia mainly includes the following aspects: A: androgen; B: immunosuppressive therapy: such as cyclosporine A, ATG, high-dose methylprednisolone, high-dose gamma ball, etc.; C: improve microcirculation such as 654-2, etc.; the first choice drug for the treatment of chronic aplastic anemia is "androgen", which stimulates hematopoiesis in cells under the bone marrow, and has a good curative effect on chronic aplastic anemia, with a total effective rate of about 70%-80%, but androgen therapy for chronic aplastic anemia The effect of aplastic anemia is slow, whether it is injection or oral administration, it takes at least two months to see the first curative effect, and some patients have curative effect later, generally after 6 months of continuous treatment, those who are still ineffective are considered to be ineffective against androgen and give up. Therefore, we will continue to treat for at least half a year, and the side effects of hormone therapy are relatively large, and the treatment cost is very high.